PubRank

Harry Schachter

Author PubWeight™ 27.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med 2004 3.00
2 O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 2010 2.98
3 ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet 2012 1.93
4 Walker-Warburg syndrome. Orphanet J Rare Dis 2006 1.59
5 Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa. Biochim Biophys Acta 2002 1.20
6 Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. Cancer Res 2008 1.17
7 Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span. J Biol Chem 2006 1.14
8 Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I. Biochem J 2002 1.10
9 Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol 2008 1.05
10 Caenorhabditis elegans triple null mutant lacking UDP-N-acetyl-D-glucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I. Biochem J 2004 0.97
11 Synthesis of paucimannose N-glycans by Caenorhabditis elegans requires prior actions of UDP-N-acetyl-D-glucosamine:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I, alpha3,6-mannosidase II and a specific membrane-bound beta-N-acetylglucosaminidase. Biochem J 2003 0.96
12 Neuronal expression of Mgat1 rescues the shortened life span of Drosophila Mgat11 null mutants and increases life span. Proc Natl Acad Sci U S A 2010 0.95
13 N-glycans are involved in the response of Caenorhabditis elegans to bacterial pathogens. Methods Enzymol 2006 0.91
14 The PCome of Caenorhabditis elegans as a prototypic model system for parasitic nematodes: identification of phosphorylcholine-substituted proteins. Mol Biochem Parasitol 2008 0.86
15 Carriers and patients with muscle-eye-brain disease can be rapidly diagnosed by enzymatic analysis of fibroblasts and lymphoblasts. Neuromuscul Disord 2006 0.83
16 A method for proteomic identification of membrane-bound proteins containing Asn-linked oligosaccharides. Anal Biochem 2004 0.83
17 Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents. Clin Biochem 2003 0.83
18 UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II in Caenorhabditis elegans. Biochim Biophys Acta 2002 0.82
19 Walker-Warburg Syndrome with POMT1 mutations can be associated with cleft lip and cleft palate. Neuromuscul Disord 2008 0.81
20 Suppression of cancer progression by MGAT1 shRNA knockdown. PLoS One 2012 0.81
21 Identification of the hydrophobic glycoproteins of Caenorhabditis elegans. Glycobiology 2005 0.80
22 Two closely related forms of UDP-GlcNAc: alpha6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II occur in the clawed frog Xenopus laevis. Glycoconj J 2002 0.79
23 Isolation of null alleles of the Caenorhabditis elegans gly-12, gly-13 and gly-14 genes, all of which encode UDP-GlcNAc: alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I activity. Biochimie 2003 0.79
24 Gene inactivation confirms the identity of enzymes involved in nematode phosphorylcholine-N-glycan synthesis. Mol Biochem Parasitol 2007 0.77
25 Scientific progress and the common good: the dilemma of recombinant DNA. Leg Med Q 1977 0.75
26 Robert Spiro Obituary. Glycoconj J 2015 0.75
27 Robert Gunter Spiro. Glycobiology 2015 0.75